Reinhart Partners’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-399,287
Closed -$14.3M 80
2022
Q2
$14.3M Sell
399,287
-5,217
-1% -$211K 0.78% 62
2022
Q1
$19.9M Buy
404,504
+15,449
+4% +$817K 0.96% 47
2021
Q4
$21.7M Buy
389,055
+190,737
+96% +$10.5M 1.04% 40
2021
Q3
$11.5M Sell
198,318
-16,050
-7% -$989K 0.58% 75
2021
Q2
$13.6M Sell
214,368
-173
-0.1% -$11.4K 0.67% 71
2021
Q1
$13.7M Sell
214,541
-88,712
-29% -$5.15M 0.71% 65
2020
Q4
$15.9M Sell
303,253
-27,619
-8% -$1.36M 0.96% 56
2020
Q3
$14.5M Buy
330,872
+26,667
+9% +$1.18M 1.09% 53
2020
Q2
$13.4M Buy
+304,205
New +$12.9M 1.02% 56

Other funds holding XRAY

Reinhart Partners's XRAY Position: Q3 2022 in Review

Reinhart Partners sold out of Dentsply Sirona (XRAY) in Q3 2022, closing a stake of 399,287 shares — an estimated $14.3M sold.

Reinhart Partners first reported a position in XRAY in Q2 2020 and held it in 9 quarters. The position peaked at $21.7M in Q4 2021. 460 funds tracked by Wall St. Rank hold XRAY as of Q3 2022.

  • Reinhart Partners reported no remaining Dentsply Sirona position as of Q3 2022 after selling out during the quarter.
  • Reinhart Partners sold 399,287 Dentsply Sirona shares in Q3 2022, an estimated $14.3M.
  • Reinhart Partners first reported a position in Dentsply Sirona in Q2 2020 and held it in 9 quarters.
  • Reinhart Partners's Dentsply Sirona position peaked at $21.7M in Q4 2021.
  • 460 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2022.

Based on Reinhart Partners's 13F filing for Q3 2022, filed 1 Nov 2022.